Duloxetine Capsule, Delayed Release
Product Images NDC 68001-595
Product Visual Gallery
This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 68001-595). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure1 (Duloxetine Fig1)
Figure2 (Duloxetine Fig2)
Figure3 (Duloxetine Fig3)
Figure4 (Duloxetine Fig4)
Figure5 (Duloxetine Fig5)
Figure6 (Duloxetine Fig6)
Figure7 (Figure 7)
Figure8 (Duloxetine Fig8)
Figure9 (Duloxetine Fig9)
Figure10 (Duloxetine Fig10)
20mg Bharuch (Dulox Dr Caps 20mg (60ct) Bharuch Site Rev 0325)
20mg Paithan (Dulox Dr Caps 20mg (60ct) Paithan Site Rev 0325)
30mg Bharuch (Dulox Dr Caps 30mg (30ct) Bharuch Site Rev 0325)
30mg Paithan (Dulox Dr Caps 30mg (30ct) Paithan Site Rev 0325)
40mg Bharuch (Dulox Dr Caps 40mg (30ct) Bharuch Site Rev 0325)
40mg Paithan (Dulox Dr Caps 40mg (30ct) Paithan Site Rev 0325)
60mg Bharuch (Dulox Dr Caps 60mg (30ct) Bharuch Site Rev 0325)
60mg (Dulox Dr Caps 60mg (30ct) Paithan Site Rev 0325)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.